JP2015521034A5 - - Google Patents

Download PDF

Info

Publication number
JP2015521034A5
JP2015521034A5 JP2015510377A JP2015510377A JP2015521034A5 JP 2015521034 A5 JP2015521034 A5 JP 2015521034A5 JP 2015510377 A JP2015510377 A JP 2015510377A JP 2015510377 A JP2015510377 A JP 2015510377A JP 2015521034 A5 JP2015521034 A5 JP 2015521034A5
Authority
JP
Japan
Prior art keywords
pet food
layer
food supplement
melting point
symbol placement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015510377A
Other languages
English (en)
Japanese (ja)
Other versions
JP6240161B2 (ja
JP2015521034A (ja
Filing date
Publication date
Priority claimed from US13/460,989 external-priority patent/US20130295227A1/en
Application filed filed Critical
Publication of JP2015521034A publication Critical patent/JP2015521034A/ja
Publication of JP2015521034A5 publication Critical patent/JP2015521034A5/ja
Application granted granted Critical
Publication of JP6240161B2 publication Critical patent/JP6240161B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015510377A 2012-05-01 2013-04-30 敏感な成分を含む組成物 Active JP6240161B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/460,989 2012-05-01
US13/460,989 US20130295227A1 (en) 2012-05-01 2012-05-01 Composition Comprising a Sensitive Ingredient
PCT/US2013/038826 WO2013165993A1 (en) 2012-05-01 2013-04-30 Composition comprising a sensitive ingredient

Publications (3)

Publication Number Publication Date
JP2015521034A JP2015521034A (ja) 2015-07-27
JP2015521034A5 true JP2015521034A5 (enExample) 2016-07-14
JP6240161B2 JP6240161B2 (ja) 2017-11-29

Family

ID=48407826

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015510377A Active JP6240161B2 (ja) 2012-05-01 2013-04-30 敏感な成分を含む組成物

Country Status (8)

Country Link
US (1) US20130295227A1 (enExample)
JP (1) JP6240161B2 (enExample)
CN (1) CN104619191B (enExample)
AU (3) AU2013256554A1 (enExample)
BR (1) BR112014027301A8 (enExample)
CA (1) CA2872411C (enExample)
RU (1) RU2632489C2 (enExample)
WO (1) WO2013165993A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
MX348960B (es) * 2012-09-13 2017-07-04 Specialites Pet Food Uso de composiciones grasas para mantener una palatabilidad mejorada de alimentos para animales domesticos en el tiempo.
CA2951739C (en) 2014-07-01 2023-09-19 Tntgamble, Inc. Bi-layer dual release probiotic tablets
JP7229675B2 (ja) * 2018-05-18 2023-02-28 ユニ・チャーム株式会社 ペットフード、粒状ペットフード、及びペットフードの製造方法
JP6424289B1 (ja) * 2018-06-27 2018-11-14 ユニ・チャーム株式会社 ペットフード、粒状ペットフード、及びペットフードの製造方法
JP6423983B1 (ja) * 2018-08-29 2018-11-14 ユニ・チャーム株式会社 ペットフード、粒状ペットフード、及びペットフードの製造方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU54410A1 (enExample) * 1967-08-30 1969-06-10
US3966997A (en) * 1973-12-10 1976-06-29 Shade Foods, Inc. Chocolate solid wafer and method of manufacture
US5573850A (en) * 1995-03-24 1996-11-12 Alliedsignal Inc. Abrasion resistant quasi monofilament and sheathing composition
US6117477A (en) * 1998-03-18 2000-09-12 Kal Kan Foods, Inc. Multicomponent food product and methods of making and using the same
CZ301663B6 (cs) * 2000-07-19 2010-05-19 Kraft Foods Global Brands Llc Probiotický výrobek
EP1344458A1 (en) 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
CA2513260C (en) * 2003-01-31 2013-01-08 Childrens Hospital Los Angeles Oral compositions of fenretinide having increased bioavailability and methods of using the same
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20060228448A1 (en) 2005-04-11 2006-10-12 The Iams Company Pet food compositions comprising two components
FR2886200B1 (fr) 2005-05-27 2009-10-16 Aplix Sa Assemblage moule-surmoule a action anti remontee
BRPI0611493B1 (pt) 2005-05-31 2022-04-05 Alimentary Health Ltd. Lactobacilos probióticos felinos
JP2007330180A (ja) * 2006-06-16 2007-12-27 Iris Ohyama Inc ペットフード及びその製造方法
AU2008206670A1 (en) * 2007-01-19 2008-07-24 The Iams Company Composition and method of stabilized sensitive ingredient
EP2164350A2 (en) * 2007-07-13 2010-03-24 Unilever N.V. Composition comprising bacteria and lecithin
IL199781A0 (en) * 2009-07-09 2010-05-17 Yohai Zorea Heat resistant probiotic compositions and healthy food comprising them
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US10104903B2 (en) * 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2384647A1 (en) * 2010-05-07 2011-11-09 Adexgo Ltd. Feed additive compositions and method for the production thereof
US20120156330A1 (en) * 2010-12-16 2012-06-21 Nakhasi Dilip K Low sodium margarine spread enriched with probiotics field

Similar Documents

Publication Publication Date Title
JP2015521034A5 (enExample)
Kvakova et al. Co-encapsulated synbiotics and immobilized probiotics in human health and gut Microbiota modulation
Mishra et al. Advances in probiotics, prebiotics and nutraceuticals
Sharma et al. Antibiotic resistance among commercially available probiotics
Blazheva et al. Antioxidant potential of probiotics and postbiotics: a biotechnological approach to improving their stability
Twetman Are we ready for caries prevention through bacteriotherapy?
RU2020112241A (ru) Новые приемы для лечения инфекций clostridium difficile
JP2018526370A5 (enExample)
Eckert et al. Development of alginate-pectin microparticles with dairy whey using vibration technology: Effects of matrix composition on the protection of Lactobacillus spp. from adverse conditions
RU2016129186A (ru) Композиция, содержащая пробиотические бактерии, для применения в лечении иммунных расстройств
ME03805B (me) UPOTREBA KOMPOZICIJE KOlA OBUHVATA MIKROORGANIZME ZA POVEĆANJE INTESTINALNE PROIZVODNJE BUTERNE KISELINE, FOLNE KISELINE ILI NIACINA I/ILI SMANJENJE INTESTINALNE PROIZVODNJE ĆILIBARNE KISELINE
JP2019508486A5 (enExample)
AR076862A1 (es) Microorganismos no replicantes y su efecto de refuerzo inmunologico. composicion. metodo para aumentar efectividad de probioticos
RU2011127463A (ru) Композиции, предназначенные для младенцев с низкой массой тела при рождении
JP2015213501A5 (enExample)
RU2015129066A (ru) Применение bifidobacterium animalis для лечения или предотвращения набора веса и инсулинорезистентности
JP2016537410A5 (enExample)
HRP20210995T1 (hr) Uporaba probiotika u liječenju i/ili prevenciji atopičnog dermatitisa
RU2018136939A (ru) Применение пробиотиков для лечения и/или профилактики псориаза
Furtado et al. Bacteriocinogenic Lactococcus lactis subsp: lactis DF04Mi isolated from goat milk: Evaluation of the probiotic potential
Jiménez-Villeda et al. Synbiotic encapsulation: a trend towards increasing viability and probiotic effect
CA2817217A1 (en) Powdered cereal compositions comprising non-replicating probiotic microorganisms
JP2019535828A5 (enExample)
WO2015018883A3 (en) Probiotic for infantile excessive crying
RU2015122748A (ru) Применение штамма lactobacillus rhamnosus для уменьшения прибавления в весе и/или инсулинорезистентности